← Back to Search

Alianza Latina Program for Dementia

Phase 1
Recruiting
Led By Jaime Perales Puchalt, PhD, MPH
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with mild cognitive impairment or dementia
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during the 15 months of the whole intervention period
Awards & highlights

Study Summary

This trial will test a new way to provide care for Latinos with dementia and their caregivers.

Who is the study for?
This trial is for Latinos aged 65+ living in the community with mild cognitive impairment or dementia, who have a caregiver and access to a cell phone with flat-fee texting. It's not for those without Latino identity, no diagnosis of cognitive issues, no caregiver, or lacking appropriate cell phone access.Check my eligibility
What is being tested?
The study tests 'Alianza Latina,' where primary care practitioners are trained to better detect and manage dementia among Latinos. They refer patients to Health Navigators who offer care management and support services.See study design
What are the potential side effects?
Since this trial focuses on training and support services rather than medication, traditional side effects aren't expected. However, participants may experience emotional or psychological impacts from discussing sensitive health information.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with mild cognitive impairment or dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~during the 15 months of the whole intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and during the 15 months of the whole intervention period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Importance of Navigators to providers
Overall participant satisfaction with the Navigator side of the intervention
Overall participant satisfaction with the clinic side of the intervention
+12 more
Secondary outcome measures
Caregivers' burden
Caregivers' depression
Caregivers' quality of life
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Alianza LatinaExperimental Treatment1 Intervention
The main components of Alianza Latina are 1) providing primary care providers with education, training and tools for timely dementia diagnosis and optimal treatment and 2) providing Latino dementia patients with enhanced chronic care through bilingual Health Navigators.

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
459 Previous Clinical Trials
169,004 Total Patients Enrolled
9 Trials studying Dementia
2,739 Patients Enrolled for Dementia
National Institute on Minority Health and Health Disparities (NIMHD)NIH
376 Previous Clinical Trials
1,215,056 Total Patients Enrolled
1 Trials studying Dementia
139 Patients Enrolled for Dementia
Jaime Perales Puchalt, PhD, MPHPrincipal InvestigatorKUMC

Media Library

Alianza Latina Clinical Trial Eligibility Overview. Trial Name: NCT04418232 — Phase 1
Dementia Research Study Groups: Alianza Latina
Dementia Clinical Trial 2023: Alianza Latina Highlights & Side Effects. Trial Name: NCT04418232 — Phase 1
Alianza Latina 2023 Treatment Timeline for Medical Study. Trial Name: NCT04418232 — Phase 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Has the recruitment process for this experiment commenced?

"As indicated on clinicaltrials.gov, the recruitment phase of this medical trial is currently paused; it was first uploaded on May 1st 2022 and updated lastly on April 13th 2022. Fortunately, there are almost 400 other studies actively enrolling participants at present."

Answered by AI

Is Alianza Latina an efficacious and secure option for patients?

"Our team at Power judged that Alianza Latina's safety score is a 1 because this is an early-stage clinical trial, meaning there is limited data on its efficacy and safety."

Answered by AI

What potential benefits do researchers anticipate from this trial's results?

"This 6-month clinical trial is mainly focused on assessing the importance of Navigators to providers. Secondary objectives include evaluating patients' depressive symptoms using a 15-question Short Geriatric Depression Scale, caregivers' depression through a 10-item Center for Epidemiologic Studies-Depression scale (CES-D-10), and Caregivers’ burden with 6 questions from the Short Zarit Burden Interview."

Answered by AI
~26 spots leftby Dec 2024